Policy & News
Drug Manufacturing Supervision and Administration Measures
2023-04-27
The Measures for the Supervision and Administration of Pharmaceutical Production was considered and adopted at the 1st Bureau Meeting of 2020 of the State Administration of Market Supervision and Administration on 15 January 2020, and is hereby promulgated and shall come into force from 1 July 2020 onwards.
View More
2023-04-27
Article 1 This Law is enacted for the purpose of strengthening vaccine management, ensuring the quality and supply of vaccines, regulating preventive vaccination, promoting the development of the vaccine industry, safeguarding public health and maintaining public health safety.
View More
2023-03-23
Adverse Drug Reaction Report Email: ADR<adr@curovax.net> Adverse Drug Reaction Report Tel: 81668927
View More
2023-01-09
Recently, after the strict examination and certification by the relevant leaders and experts of Jiangsu Private Science and Technology Enterprises Association, Jiangsu Kangrun Biotechnology Company Limited has been evaluated as "Jiangsu Private Science and Technology Enterprise".
View More
The company organised the election for the fifth session of the People's Congress of Xinbei District
2023-01-09
According to the arrangement of the general election work of Xinbei District People's Congress Election Committee, the voter group of Jiangsu Kangrun Biotechnology Co., Ltd. in the second constituency of Xinqiao Street, Xinbei District, voted for the election on 6 December 2021, and 127 employees of the company took part in the voting.
View More
World's first new plant-based crown vaccine approved in Canada
2023-01-09
Canada has become the first country in the world to authorise the use of a plant-based New Crown vaccine, ABC reports. On 24 February local time, Canadian regulators said they were allowing two doses of Medicago's New Crown vaccine to be administered to adults between the ages of 18 and 64, but said there was still too little data related to people aged 65 and older.
View More
